Matches in Wikidata for { <http://www.wikidata.org/entity/Q70110464> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q70110464 description "artikull shkencor i botuar më 01 janar 1985" @default.
- Q70110464 description "artículu científicu espublizáu en xineru de 1985" @default.
- Q70110464 description "im Jahr 1985 veröffentlichter wissenschaftlicher Artikel" @default.
- Q70110464 description "scientific article published on 01 January 1985" @default.
- Q70110464 description "wetenschappelijk artikel" @default.
- Q70110464 description "наукова стаття, опублікована в січні 1985" @default.
- Q70110464 name "Hydralazine and isoniazid reduce the formation of soluble immune complexes by complement" @default.
- Q70110464 name "Hydralazine and isoniazid reduce the formation of soluble immune complexes by complement" @default.
- Q70110464 name "Hydralazine and isoniazid reduce the formation of soluble immune complexes by complement" @default.
- Q70110464 type Item @default.
- Q70110464 label "Hydralazine and isoniazid reduce the formation of soluble immune complexes by complement" @default.
- Q70110464 label "Hydralazine and isoniazid reduce the formation of soluble immune complexes by complement" @default.
- Q70110464 label "Hydralazine and isoniazid reduce the formation of soluble immune complexes by complement" @default.
- Q70110464 prefLabel "Hydralazine and isoniazid reduce the formation of soluble immune complexes by complement" @default.
- Q70110464 prefLabel "Hydralazine and isoniazid reduce the formation of soluble immune complexes by complement" @default.
- Q70110464 prefLabel "Hydralazine and isoniazid reduce the formation of soluble immune complexes by complement" @default.
- Q70110464 P1433 Q70110464-7573F8F6-06F8-4613-A726-63B9179A9BA9 @default.
- Q70110464 P1476 Q70110464-8F5F476F-5FCB-4FB1-B2CD-5CA775CC06D5 @default.
- Q70110464 P2093 Q70110464-03792A1A-7654-408F-922B-36E9672CBC53 @default.
- Q70110464 P304 Q70110464-96D1EDE6-00CB-4E64-A8F6-CF1ECA7A7DA1 @default.
- Q70110464 P31 Q70110464-9E7D3904-FFB5-48E7-90ED-7E77548A3281 @default.
- Q70110464 P356 Q70110464-903BAD7D-224C-4DB3-A183-C39DDB56C832 @default.
- Q70110464 P433 Q70110464-84D321E1-7790-4470-9293-0AE5EEB1D5A8 @default.
- Q70110464 P478 Q70110464-83E64DB8-8AE1-488D-9BB8-0EB721399BFA @default.
- Q70110464 P577 Q70110464-B3727538-56F8-4AE4-905B-3C051F684670 @default.
- Q70110464 P698 Q70110464-8DBB1FD0-F574-4213-9DB3-DDB707002BC2 @default.
- Q70110464 P921 Q70110464-44340C7B-3532-4287-93FE-0DC5A2CC140F @default.
- Q70110464 P921 Q70110464-DFC4C158-2416-4BE8-A7D4-30CAA88E62F4 @default.
- Q70110464 P356 0165-2478(85)90011-2 @default.
- Q70110464 P698 3997205 @default.
- Q70110464 P1433 Q15766068 @default.
- Q70110464 P1476 "Hydralazine and isoniazid reduce the formation of soluble immune complexes by complement" @default.
- Q70110464 P2093 "J A Schifferli" @default.
- Q70110464 P304 "297-299" @default.
- Q70110464 P31 Q13442814 @default.
- Q70110464 P356 "10.1016/0165-2478(85)90011-2" @default.
- Q70110464 P433 "5" @default.
- Q70110464 P478 "9" @default.
- Q70110464 P577 "1985-01-01T00:00:00Z" @default.
- Q70110464 P698 "3997205" @default.
- Q70110464 P921 Q419987 @default.
- Q70110464 P921 Q423169 @default.